Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Number of holders
-
16
-
Total 13F principal, excl. options
-
206M
-
Principal change
-
-2.67M
-
Total reported value, excl. options
-
$256M
-
Value change
-
-$4.68M
-
Number of buys
-
6
-
Number of sells
-
-12
-
Price
-
$0.95
Significant Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q3 2024
23 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q3 2024.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 has 16 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $206M of principal
.
Largest 10 bondholders include PenderFund Capital Management Ltd. ($40.4M of principal), Indaba Capital Management, L.P. ($33.8M of principal), Davidson Kempner Capital Management LP ($25M of principal), WHITEBOX ADVISORS LLC ($23.9M of principal), BlackRock, Inc. ($18M of principal), DeepCurrents Investment Group LLC ($17M of principal), Pentwater Capital Management LP ($10.9M of principal), Whitefort Capital Management, LP ($8M of principal), AMERIPRISE FINANCIAL INC ($6M of principal), and Jefferies Financial Group Inc. ($5.84M of principal).
This table shows the top 16 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.